|
Heart Failure, Diastolic
|
0.300 |
Biomarker
|
disease |
CTD_human |
In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction.
|
29556499 |
2018 |
|
Endometrial adenocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
|
17717078 |
2007 |
|
Carcinogenesis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Krüppel-like factor 9 (KLF9) is a transcriptional regulator of uterine endometrial cell proliferation, adhesion and differentiation; processes essential for pregnancy success and which are subverted during tumorigenesis.
|
18783612 |
2008 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
KLF9 influences the expression of uterine epithelial genes through mechanisms likely involving its transcriptional activator and repressor functions and which may underlie altered tumor biology with aberrant KLF9 expression.
|
18783612 |
2008 |
|
Colorectal Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Krüppel-like factor 9 (KLF9) is known to be a tumor suppressor gene in colorectal tumors and glioblastoma; however, the functional status and significance of KLF9 in hepatocellular carcinoma (HCC) is unclear.
|
25242357 |
2014 |
|
Glioblastoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Krüppel-like factor 9 (KLF9) is known to be a tumor suppressor gene in colorectal tumors and glioblastoma; however, the functional status and significance of KLF9 in hepatocellular carcinoma (HCC) is unclear.
|
25242357 |
2014 |
|
Glioblastoma Multiforme
|
0.040 |
Biomarker
|
disease |
BEFREE |
Krüppel-like factor 9 (KLF9) is known to be a tumor suppressor gene in colorectal tumors and glioblastoma; however, the functional status and significance of KLF9 in hepatocellular carcinoma (HCC) is unclear.
|
25242357 |
2014 |
|
Adult Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Krüppel-like factor 9 (KLF9) is known to be a tumor suppressor gene in colorectal tumors and glioblastoma; however, the functional status and significance of KLF9 in hepatocellular carcinoma (HCC) is unclear.
|
25242357 |
2014 |
|
Childhood Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Krüppel-like factor 9 (KLF9) is known to be a tumor suppressor gene in colorectal tumors and glioblastoma; however, the functional status and significance of KLF9 in hepatocellular carcinoma (HCC) is unclear.
|
25242357 |
2014 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Krüppel-like factor 9 (KLF9) has been found to play suppressive roles in several types of tumor.
|
25641762 |
2016 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Krüppel-like factor 9 (KLF9) is a haploinsufficient tumor suppressor in the ApcMin/+ mouse colon by suppressing expression of ISG15, an apoptosis-inhibiting cytokine.
|
26210742 |
2015 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
KLF9 is the core effector protein that might suppress tumor growth.
|
27956179 |
2017 |
|
Pancreatic Ductal Adenocarcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
KLF9 expression was found to be a valuable prognostic factor for patients with pancreatic ductal adenocarcinoma.
|
28668877 |
2017 |
|
Tumor Cell Invasion
|
0.080 |
AlteredExpression
|
phenotype |
BEFREE |
Krüppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion.
|
29107105 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Krüppel-like factor 9 (KLF9) plays critical roles in several types of tumor.
|
29107105 |
2018 |
|
Adult Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
|
30348136 |
2018 |
|
Childhood Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
|
30348136 |
2018 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Kruppel-like factor 9 (KLF9), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear.
|
30542730 |
2018 |
|
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
KLF9 may have potential diagnostic and therapeutic values in this type of cancer.
|
30542730 |
2018 |
|
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
KLF9 may have potential diagnostic and therapeutic values in this type of cancer.
|
30542730 |
2018 |
|
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Klf9 deficiency inhibited premalignant melanocytic hyperplasia in Braf<sup>CA</sup> mice but did not affect formation and growth of Braf<sup>CA</sup>/Pten<sup>-/-</sup> primary melanomas.
|
30664687 |
2019 |
|
Neoplasm Metastasis
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
KLF9 overexpression significantly stimulated the proliferation and metastasis of MGC-803 and BGC-823 cells.
|
30746617 |
2019 |
|
Neoplasm Metastasis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.
|
30913394 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Krüppel-like factor 9 (KLF9) has prodifferentiation and tumor suppression functions in several types of cancers.
|
31782614 |
2020 |
|
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
Krüppel-like factor 9 (<i>KLF9</i>) belongs to a family of transcriptional regulators and its role in BC has not been fully investigated.
|
31819488 |
2019 |